In model 3, women with HER2-enriched and triple-negative tumors were significantly more likely to die of breast cancer as compared to luminal A with hazard ratios of 5.31 (95% CI 3.82–7.40) and 12.93 (95% CI 10.62–15.73), respectively. The gene discussed is ERBB2; the disease is breast cancer.